The boss of U.S. drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British jobs in his proposed joint creation with AstraZeneca of a global powerhouse upon which he says the latter's future depends.Ian Read faces hostile questions in parliament over his proposed $106 billion play for AstraZeneca. He goes into committee hearings having pledged to keep a fifth of research jobs in Britain, and warned the country's second biggest drugmaker could wither without Pfizer's financial muscle.Pfizer's bid would be the largest foreign takeover of a British firm and is opposed by many scientists and politicians, as well as AstraZeneca itself.The British company rushed out further details on its new drug pipeline early on Tuesday morning, highlighting positive late-stage trial results with a diabetes drug combination called saxagliptin/dapagliflozin. It also flagged good news on four drugs for asthma, rheumatoid arthritis and lupus on Monday - aiming to prove it can stand on its own.
Tuesday Morning Corporation is a closeout retailer of upscale decorative home accessories, housewares, and famous-maker gifts in the United States. Shares of TUES fell by 0.86% or $-0.13/share to $14.96. In the past year, the shares have traded as low as $7.66 and as high as $16.60. On average, 401013 shares of TUES exchange hands on a given day and today's volume is recorded at 1082468.
Source
